Ryuichi Tsujita

463 total citations
17 papers, 369 citations indexed

About

Ryuichi Tsujita is a scholar working on Molecular Biology, Organic Chemistry and Pharmacology. According to data from OpenAlex, Ryuichi Tsujita has authored 17 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 4 papers in Organic Chemistry and 3 papers in Pharmacology. Recurrent topics in Ryuichi Tsujita's work include Neuroscience and Neuropharmacology Research (3 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers) and Pharmacological Receptor Mechanisms and Effects (2 papers). Ryuichi Tsujita is often cited by papers focused on Neuroscience and Neuropharmacology Research (3 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers) and Pharmacological Receptor Mechanisms and Effects (2 papers). Ryuichi Tsujita collaborates with scholars based in Japan, United States and Germany. Ryuichi Tsujita's co-authors include Koh Kawasaki, Daisuke Mochizuki, Fumiko Sekiguchi, Atsufumi Kawabata, Maho Tsubota, Shinji Yamada, Shinji Hashimoto, Yoshihisa Kitamura, Yuji Otsuka and Naomasa Miki and has published in prestigious journals such as Biochemical and Biophysical Research Communications, Journal of Medicinal Chemistry and British Journal of Pharmacology.

In The Last Decade

Ryuichi Tsujita

17 papers receiving 358 citations

Peers

Countries citing papers authored by Ryuichi Tsujita

Since Specialization

Citations

This map shows the geographic impact of Ryuichi Tsujita's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ryuichi Tsujita with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ryuichi Tsujita more than expected).

Fields of papers citing papers by Ryuichi Tsujita

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ryuichi Tsujita. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ryuichi Tsujita. The network helps show where Ryuichi Tsujita may publish in the future.

Co-authorship network of co-authors of Ryuichi Tsujita

This figure shows the co-authorship network connecting the top 25 collaborators of Ryuichi Tsujita. A scholar is included among the top collaborators of Ryuichi Tsujita based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ryuichi Tsujita. Ryuichi Tsujita is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Role of high‐mobility group box 1 and its modulation by thrombomodulin/thrombin axis in neuropathic and inflammatory pain 2020 ·British Journal of Pharmacology ·Ryuichi Tsujita, Maho Tsubota, Fumiko Sekiguchi, Atsufumi Kawabata	28
2	Thrombomodulin alfa prevents oxaliplatin-induced neuropathic symptoms through activation of thrombin-activatable fibrinolysis inhibitor and protein C without affecting anti-tumor activity 2020 ·European Journal of Pharmacology ·(unknown), (unknown), M. Sata, Hiroki Kato, Kazuo Yano, Takumi Sakai, Ryuichi Tsujita, Koh Kawasaki, Akitoshi ITO	11
3	Thrombomodulin induces anti-inflammatory effects by inhibiting the rolling adhesion of leukocytes in vivo 2020 ·Journal of Pharmacological Sciences ·(unknown), Junichi Kikuta, Shigeto Seno, Masahiro Kajiki, Ryuichi Tsujita, Hiroki Mizuno, Takao Sudo, Tomoka Ao, Hideo Matsuda, Masaru Ishii	7
4	HMGB1 as a target for prevention of chemotherapy-induced peripheral neuropathy 2019 ·Folia Pharmacologica Japonica ·Atsufumi Kawabata, Maho Tsubota, Fumiko Sekiguchi, Ryuichi Tsujita	2
5	Role of Thrombin in Soluble Thrombomodulin-Induced Suppression of Peripheral HMGB1-Mediated Allodynia in Mice 2017 ·Journal of Neuroimmune Pharmacology ·Ryuichi Tsujita, Maho Tsubota, Yusuke Hayashi, (unknown), Fumiko Sekiguchi, Atsufumi Kawabata	16
6	Human soluble thrombomodulin-induced blockade of peripheral HMGB1-dependent allodynia in mice requires both the lectin-like and EGF-like domains 2017 ·Biochemical and Biophysical Research Communications ·Yusuke Hayashi, Ryuichi Tsujita, Maho Tsubota, (unknown), Fumiko Sekiguchi, Goichi Honda, Atsufumi Kawabata	14
7	Post-marketing surveillance data of thrombomodulin alfa: sub-analysis in patients with sepsis-induced disseminated intravascular coagulation 2014 ·Journal of Intensive Care ·Yutaka Eguchi, Satoshi Gando, Hiroyasu Ishikura, Daizoh Saitoh, Jun Mimuro, Hoyu Takahashi, Isao Kitajima, Hajime Tsuji, Tadashi Matsushita, Ryuichi Tsujita, (unknown), Yoichi Sakata	25
8	The effects of AP521, a novel anxiolytic drug, in three anxiety models and on serotonergic neural transmission in rats 2014 ·Journal of Pharmacological Sciences ·K. Kasahara, Shinji Hashimoto, Tsuyoshi Hattori, Koh Kawasaki, Ryuichi Tsujita, (unknown), (unknown), (unknown), (unknown)	12
9	Discovery of selective PDE4B inhibitors 2009 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), (unknown), (unknown), Masahiro Saitoh, Naoto Ohkawa, Takashi Kubôta, Hiromitsu Nagumo, (unknown), (unknown), (unknown), Junji Nakamura, Ryuichi Tsujita, Koh Kawasaki, (unknown), Masashi Kawanishi	87
10	Identification of Structurally Diverse Growth Hormone Secretagogue Agonists by Virtual Screening and Structure−Activity Relationship Analysis of 2-Formylaminoacetamide Derivatives 2004 ·Journal of Medicinal Chemistry ·(unknown), Takeo Harada, (unknown), Ryuichi Tsujita, (unknown), Hiroyuki Kouji, Florence L. Stahura, Ling Xue, Jürgen Bajorath	18
11	A Method for Designing Conformationally Restricted Analogues Based on Allylic Strain: Synthesis of a Novel Class of Noncompetitive NMDA Receptor Antagonists Having the Acrylamide Structure 2003 ·Journal of Medicinal Chemistry ·(unknown), (unknown), Ryuichi Tsujita, Tamotsu Yamamoto, (unknown), Akira Matsuda, Satoshi Shuto	12
12	Synthesis of derivatives of (1S,2R)-1-phenyl-2-[(S)-1-aminopropyl]-N,N-diethylcyclopropanecarboxamide (PPDC) modified at the 1-aromatic moiety as novel NMDA receptor antagonists: the aromatic group is essential for the activity 2002 ·Bioorganic & Medicinal Chemistry ·Yuji Kazuta, Ryuichi Tsujita, (unknown), Shigeo Uchino, Shinichi Kohsaka, Akira Matsuda, Satoshi Shuto	18
13	Neurochemical and behavioural characterization of milnacipran, a serotonin and noradrenaline reuptake inhibitor in rats 2002 ·Psychopharmacology ·Daisuke Mochizuki, Ryuichi Tsujita, Shinji Yamada, Koh Kawasaki, Yuji Otsuka, Shinji Hashimoto, Tsuyoshi Hattori, Yoshihisa Kitamura, Naomasa Miki	91
14	Synthesis of (1S,2R)-1-phenyl-2-[(S)-1-aminoalkyl]-N,N-diethylcyclopropanecarboxamides as novel NMDA receptor antagonists having a unique NMDA receptor subtype selectivity 2002 ·Journal of the Chemical Society Perkin Transactions 1 ·Yuji Kazuta, Ryuichi Tsujita, Shigeo Uchino, (unknown), Daisuke Mochizuki, (unknown), (unknown), (unknown), Tamotsu Yamamoto, (unknown), Akira Matsuda, Satoshi Shuto	6
15	An aromatic moiety is not essential for pharmacophore binding to sigma binding sites: Synthesis of N-alkylazacycloheptane derivatives as potent sigma ligands 1997 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Nobuyuki Takahashi, Daisuke Mochizuki, Ryuichi Tsujita, Shinji Yamada, (unknown), Yukio Suzuki, Hideyuki Watanabe	6
16	AP521 is a novel anxiolytic drug (1) 1997 ·The Japanese Journal of Pharmacology ·(unknown), (unknown), Koh Kawasaki, (unknown), (unknown), K. Kasahara, (unknown), Shinji Yamada, Ryuichi Tsujita, (unknown), Daisuke Mochizuki, (unknown)	1
17	Cloning and expression of the human 5-HT1B-type receptor gene 1992 ·Biochemical and Biophysical Research Communications ·Daisuke Mochizuki, (unknown), Ryuichi Tsujita, Hisayuki Komaki, Hitoshi Sagai	15

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact